We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.67%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$441M
AUM Growth
+$91.2M
(+26%)
Cap. Flow
+$74.5M
Cap. Flow
% of AUM
16.9%
Top 10 Holdings %
Top 10 Hldgs %
24.04%
Holding
1,099
New
222
Increased
266
Reduced
262
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$15.4M |
| 2 |
Stellantis
STLA
|
+$9.9M |
| 3 |
Alcon
ALC
|
+$7.77M |
| 4 |
Amazon
AMZN
|
+$6.64M |
| 5 |
Ferrari
RACE
|
+$5.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Taiwan ETF
EWT
|
+$8.02M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$6.88M |
| 3 |
Linde
LIN
|
+$5.74M |
| 4 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$5.13M |
| 5 |
iShares MSCI Turkey ETF
TUR
|
+$4.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.26% |
| 2 | Technology | 13.6% |
| 3 | Financials | 12.86% |
| 4 | Healthcare | 10.91% |
| 5 | Industrials | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Futu Holdings
FUTU
$13.9B
| $413K | 0.09% |
3,057
+1,030
| +51% | +$150K |
|
227
Uber
UBER
$134B
| $412K | 0.09% |
8,573
-1,899
| -18% | -$99.2K |
|
228
D.R. Horton
DHI
$41B
| $412K | 0.09% |
4,761
+3,714
| +355% | +$349K |
|
229
ASML
ASML
$675B
| $412K | 0.09% |
+583
| New | +$385K |
|
230
DexCom
DXCM
$27.6B
| $411K | 0.09% |
3,680
+720
| +24% | +$69.1K |
|
|
OPA.U
231
DELISTED
Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant
OPA.U
| $409K | 0.09% |
41,000
| – | – |
|
|
ACTDU
232
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
| $404K | 0.09% |
40,000
| – | – |
|
233
Cheniere Energy
LNG
$56.5B
| $404K | 0.09% |
+4,814
| New | +$392K |
|
234
Teradyne
TER
$54.8B
| $400K | 0.09% |
3,153
-997
| -24% | -$128K |
|
235
PUT
Deutsche Bank
DB
$66.3B
| $397K | 0.09% |
5,069
-2,711
| -35% | -$36.8K |
|
236
Conagra Brands
CAG
$7.07B
| $386K | 0.09% |
11,352
-1
| -0% | -$37 |
|
237
Celsius Holdings
CELH
$6.93B
| $385K | 0.09% |
16,104
-5,154
| -24% | -$105K |
|
238
Eldorado Gold
EGO
$8.31B
| $383K | 0.09% |
39,267
+3,695
| +10% | +$41.1K |
|
239
DuPont de Nemours
DD
$18.6B
| $383K | 0.09% |
3,860
-260
| -6% | -$26.1K |
|
240
Global X Cloud Computing ETF
CLOU
$224M
| $382K | 0.09% |
13,340
| – | – |
|
241
KLA
KLAC
$275B
| $374K | 0.08% |
12,010
-6,480
| -35% | -$208K |
|
242
Take-Two Interactive
TTWO
$43B
| $367K | 0.08% |
2,113
+75
| +4% | +$13.3K |
|
|
DQ
243
Daqo New Energy
DQ
$790M
| $359K | 0.08% |
4,964
+2,966
| +148% | +$213K |
|
244
First Trust NASDAQ Cybersecurity ETF
CIBR
$13.8B
| $359K | 0.08% |
+7,500
| New | +$333K |
|
245
Comcast
CMCSA
$79.1B
| $358K | 0.08% |
6,200
+29
| +0.5% | +$1.62K |
|
246
A.O. Smith
AOS
$8.38B
| $355K | 0.08% |
5,004
-3,610
| -42% | -$249K |
|
247
Match Group
MTCH
$8.84B
| $355K | 0.08% |
2,154
+68
| +3% | +$9.96K |
|
248
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$166M
| $353K | 0.08% |
6,348
+600
| +10% | +$31.2K |
|
249
Eli Lilly
LLY
$1.07T
| $352K | 0.08% |
1,498
+101
| +7% | +$20.3K |
|
250
Denison Mines
DNN
$2.63B
| $349K | 0.08% |
320,566
-236,455
| -42% | -$284K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2021 Portfolio in Review
As of Q2 2021, Exane Derivatives held 1,099 positions worth $441M, up 26% from $350M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Exane Derivatives deployed $74.5M of net new capital in Q2 2021, opening 222 new positions and adding to 266 existing holdings. Its largest new stake was Alcon: 109,041 shares worth $7.62M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI Taiwan ETF, an estimated $8.02M trimmed.
- Exane Derivatives's largest Q2 2021 buy was Alcon: 109,041 shares worth $7.62M.
- Exane Derivatives added most to UBS Group in Q2 2021, an estimated $15.4M increase.
- Exane Derivatives's biggest Q2 2021 reduction was iShares MSCI Taiwan ETF, cutting an estimated $8.02M.
- Exane Derivatives fully exited Deutsche Bank in Q2 2021, selling an estimated $4.27M.
- Exane Derivatives's ten largest holdings make up 24% of its $441M portfolio in Q2 2021.
- Exane Derivatives opened 222 new positions and closed 55 in Q2 2021.
- Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $441M.
Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.